SS
IONS icon

SBI Securities’s Ionis Pharmaceuticals IONS Stock Holding History

SBI Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Sell
132
-29
-18% -$2.18K ﹤0.01% 1810
2026
Q1 		$12.1K Sell
161
-125
-44% -$9.87K ﹤0.01% 1647
2025
Q4 		$22.6K Buy
286
+19
+7% +$1.43K ﹤0.01% 1392
2025
Q3 		$17.5K Buy
267
+10
+4% +$488 ﹤0.01% 1511
2025
Q2 		$10.2K Sell
257
-3
-1% -$98 ﹤0.01% 1697
2025
Q1 		$7.84K Buy
260
+4
+2% +$131 ﹤0.01% 1699
2024
Q4 		$8.95K Buy
+256
New +$9.57K ﹤0.01% 1691

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SBI Securities's IONS Position: Q2 2026 in Review

SBI Securities reduced its Ionis Pharmaceuticals (IONS) stake by 18% in Q2 2026, selling an estimated $2.18K and leaving 132 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

SBI Securities first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. The position peaked at $22.6K in Q4 2025. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • SBI Securities held 132 shares of Ionis Pharmaceuticals worth $10.5K as of Q2 2026.
  • SBI Securities sold 29 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.18K.
  • Ionis Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1810 holding.
  • SBI Securities first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Ionis Pharmaceuticals position peaked at $22.6K in Q4 2025.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.